Provided by Tiger Trade Technology Pte. Ltd.

Bluejay Diagnostics Inc

1.96
-0.0200-1.01%
Post-market: 1.85-0.1100-5.61%16:09 EDT
Volume:7.90K
Turnover:15.05K
Market Cap:2.03M
PE:-0.13
High:1.98
Open:1.98
Low:1.83
Close:1.98
52wk High:40.80
52wk Low:1.70
Shares:1.03M
Float Shares:844.20K
Volume Ratio:0.37
T/O Rate:0.94%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-15.2513
EPS(LYR):-456.7450
ROE:-117.02%
ROA:-62.76%
PB:0.34
PE(LYR):0.00

Loading ...

Bluejay Diagnostics sells 62,500 shares in private placement for USD 125,000

Reuters
·
Mar 18

Bluejay Diagnostics’ Symphony IL-6 sepsis study accepted for SAEM annual meeting presentation

Reuters
·
Mar 12

NorthStrive Fund urges Bluejay to evaluate strategic opportunity

TIPRANKS
·
Mar 11

Northstrive Fund Ii: Recommending Bluejay Board Evaluates a Strategic Opportunity

THOMSON REUTERS
·
Mar 11

Northstrive Fund Ii:Letter Recommend Bluejay Board Review Potential Acquisition of Phase-1-Ready Therapeutic Asset Targeting Refractory Chronic Cough

THOMSON REUTERS
·
Mar 11

Northstrive Fund Ii Lp Issues Open Letter to the Board and Shareholders of Bluejay Diagnostics

THOMSON REUTERS
·
Mar 11

Bluejay Diagnostics FY2025 net loss narrows 11% to $6.85 million as interest expense plunges 100% to $0 million

Reuters
·
Mar 07

Bluejay Diagnostics Outlines 2026 Plans to Complete SYMON II Study, Advance Toward Regulatory Submission, Scale Manufacturing for Commercialization and Raise Additional Capital

Reuters
·
Mar 06

Bluejay Diagnostics Inc - Will Need to Raise at Least $20 Mln of Further Capital Through End of FY2027

THOMSON REUTERS
·
Mar 06

Bluejay Diagnostics Provides Corporate Update and 2026 Strategic Outlook

GlobeNewswire
·
Mar 06

Bluejay Diagnostics Says All Prefunded Warrants Have Been Exercised

Reuters
·
Feb 20

Bluejay Advances SYMON II Sepsis Study and Manufacturing

TIPRANKS
·
Feb 18

Bluejay Diagnostics Enrolls 545 Patients in SYMON II Clinical Study

Reuters
·
Feb 17

Bluejay Diagnostics Successfully Enrolls 545 Patients in Symon™ Ii Study and Advances Manufacturing Readiness Into 2026

THOMSON REUTERS
·
Feb 17

Bluejay Diagnostics Inc trading halted, news pending

TIPRANKS
·
Jan 29

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Jan 29

Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split

GlobeNewswire
·
Jan 27

Mirum Pharmaceuticals Completes Acquisition of Bluejay Therapeutics

Reuters
·
Jan 26

Bluejay Diagnostics Announces Completion of Commercial-Scale IL-6 Antibody Production

GlobeNewswire
·
Dec 29, 2025

Bluejay Diagnostics Reports Q3 Results and Updates

TIPRANKS
·
Nov 11, 2025